Skip to main content
editorial
. 2024 Mar 29;8(3):e59. doi: 10.1002/hem3.59

Figure 1.

Figure 1

From hypoxic gene expression signatures to antileukemic hypoxia‐inducible factor therapy. AML, acute myeloid leukemia; HSC, hematopoietic stem cell; LSC, leukemic stem cell; LTC‐IC, long‐term culture initiating cell; RNAseq, RNA‐sequencing.